Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

被引：0
|
作者：
Steven L Barriere
Martin E Stryjewski
G Ralph Corey
Fredric C Genter
Ethan Rubinstein
机构：
[1] Theravance,Duke Clinical Research Institute and Department of Medicine, Division of Infectious Diseases
[2] Inc,Section of Infectious Diseases, Department of Internal Medicine and Medical Microbiology
[3] Centro de Educación Médica e Investigaciones Clinicas (CEMIC) Norberto Quirno,undefined
[4] Duke University Medical Center,undefined
[5] University of Manitoba,undefined
来源：
BMC Infectious Diseases | / 14卷
关键词：
Vancomycin; Trough levels; Nosocomial pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [31] Relationships between on-treatment changes in glial fibrillary acidic protein levels and clinical outcomes in patients with relapsing multiple sclerosis: post hoc analysis of the phase 3 ozanimod SUNBEAM trial
    Harris, S.
    Comi, G.
    Cree, B. A. C.
    Arnold, D. L.
    Steinman, L.
    Sheffield, J. K.
    Maddux, R.
    Southworth, H.
    Kappos, L.
    Cohen, J. A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 507 - 508
  • [32] Effect of metabolic syndrome on efficacy and safety in patients with psoriasis treated with etanercept or tildrakizumab: Post hoc analysis of 2 phase 3 clinical studies (reSURFACE 1 and reSURFACE 2)
    Gottlieb, Alice B.
    Mehta, Nehal N.
    Lebwohl, Mark
    Mendelsohn, Alan M.
    Parno, Jeff
    Rozzo, Stephen J.
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB50 - AB50
  • [33] The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
    Colombo, Nicoletta
    Oza, Amit M.
    Lorusso, Domenica
    Aghajanian, Carol
    Oaknin, Ana
    Dean, Andrew
    Weberpals, Johanne, I
    Clamp, Andrew R.
    Scambia, Giovanni
    Leary, Alexandra
    Holloway, Robert W.
    Gancedo, Margarita Amenedo
    Fong, Peter C.
    Goh, Jeffrey C.
    O'Malley, David M.
    Armstrong, Deborah K.
    Banerjee, Susana
    Garcia-Donas, Jesus
    Swisher, Elizabeth M.
    Meunier, Juliette
    Cameron, Terri
    Maloney, Lara
    Goble, Sandra
    Bedel, Josh
    Ledermann, Jonathan A.
    Coleman, Robert L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 101 - 111
  • [34] A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus
    Wang, Mengqin
    Liu, Xiao
    Tian, Zhaoxing
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2023, 28 (04) : 315 - 323
  • [35] Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis-a post-hoc analysis of pooled data from three phase 3 trials with secukinumab
    Dehlin, Mats
    Fasth, Andreas E. R.
    Reinhardt, Maximilian
    Jacobsson, Lennart T. H.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (01)
  • [36] The effect of age on efficacy and safety outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase III, randomized, placebo-controlled maintenance study in patients with recurrent ovarian carcinoma
    Ledermann, J. A.
    Oza, A. M.
    Lorusso, D.
    Aghajanian, C. A.
    Oaknin, A.
    Dean, A.
    Colombo, N.
    Weberpals, J. I.
    Clamp, A. R.
    Scambia, G.
    Leary, A.
    Holloway, R. W.
    Amenedo Gancedo, M.
    Fong, P. C. C.
    Goh, J. C.
    Backes, F. J.
    Banerjee, S.
    Goble, S.
    Cameron, T.
    Coleman, R. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 4 - 5
  • [37] EFFECT OF PRIOR ESOPHAGEAL DILATION ON HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Collins, Margaret H.
    Katzka, David A.
    Mukkada, Vincent A.
    Falk, Gary W.
    Terreri, Brian
    Boules, Mena
    Zhang, Wenwen
    Desai, Nirav K.
    Dellon, Evan S.
    GASTROENTEROLOGY, 2022, 162 (07) : S530 - S530
  • [38] Impact of Psoriasis Disease Activity and Other Risk Factors on Serum-urate Levels in Patients with Psoriasis and Psoriatic Arthritis - A Post-hoc Analysis of Pooled Data from Three Phase 3-trials with Secukinumab
    Dehlin, Mats
    Fasth, Andreas
    Reinhardt, Maximilian
    Jacobsson, Lennart
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn's disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Risankizumab Studies
    Atreya, R.
    Irving, P.
    Fujiya, M.
    Colombel, J. F.
    Danese, S.
    Peyrin-Biroulet, L.
    Bessissow, T.
    Panaccione, R.
    D'Haens, G.
    van Haaren, S.
    Neimark, E.
    Zambrano, J.
    Zhang, Y.
    Kligys, K.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 675 - 676
  • [40] Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
    Kang, Jin Hyoung
    Ahn, Myung-Ju
    Kim, Dong-Wan
    Cho, Eun Kyung
    Kim, Joo-Hang
    Shin, Sang Won
    Wang, Xin
    Kim, Jong Seok
    Orlando, Mauro
    Park, Keunchil
    CANCER RESEARCH AND TREATMENT, 2016, 48 (02): : 458 - 464
12345